Macroencapsulation Membrane Slack for Controlled Cell Filling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for manufacturing implantable therapeutic devices, such as macroencapsulation devices for treating metabolic disorders, lack precision and control in forming specific structural features and are difficult to fill with biological entities like cell populations without causing excessive cell death or agglomeration.

Innovation Solution

A method of forming macroencapsulation devices by deforming membranes to fit within a frame with controlled slack, allowing for adjustable membrane relaxation to achieve desired geometrical properties and controlled filling of cells, using supports and frames to manage membrane tension and volume.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If membranes are filled with cells after device formation, then device filling is achieved, but excessive cell death and agglomeration occur

Engineering Contradiction:
Improvecell densityVSAvoidcell viability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies preliminary action by pre-forming the macroencapsulation device with defined geometrical properties and membrane slack before cell loading. The device is prepared with controlled membrane deformation and frame attachment in advance, creating optimal conditions for subsequent cell filling that prevent cell death and agglomeration during the filling process.

Inventive Principle:
Principle #10Preliminary action

2Stability of the object's composition

If membranes are rigidly fixed to frame, then structural stability is achieved, but manufacturing precision of geometrical features is lost

Engineering Contradiction:
Improvestructural stabilityVSAvoidgeometrical feature precision
Core Design Contradiction:
Stability of the object's compositionVSManufacturing precision

Solution Approach 1:

The patent applies dynamics by using a frame that provides stable structural support while allowing controlled membrane deformation. The frame is attached to the membrane in a manner that maintains structural integrity during operation but permits precise geometrical features to be formed through controlled membrane slack and deformation during manufacturing.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent applies parameter changes by controlling the degree of membrane deformation and slack as key parameters. By adjusting membrane slack and deformation levels, the device achieves both structural stability from the frame and precise geometrical features from the deformed membrane configuration.

Inventive Principle:
Principle #35Parameter changes

3Volume of stationary object

If membrane surface area is made larger than frame area, then device volume is increased, but manufacturing complexity increases

Engineering Contradiction:
Improvedevice volumeVSAvoidmanufacturing complexity
Core Design Contradiction:
Volume of stationary objectVSDevice complexity

Solution Approach 1:

The patent applies segmentation by separating the membrane formation process from the frame attachment process. The membrane is first formed with desired surface area and deformation, then the frame is attached to provide structural support. This segmentation allows independent optimization of volume (through membrane area) and simplifies manufacturing by avoiding the need to simultaneously accommodate both large membrane area and precise frame fit.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise control over device dimensions and cell density, reducing cell death and agglomeration, while providing a simple and controllable method for producing devices with defined compartments.

Implementation Method 1

the first membrane and/or the second membrane is semipermeable

Methodology Applied
Scientific EffectSemipermeable membrane: Semipermeable Membrane

Data Source

PatentUS12544545B2Macroencapsulation devices
Publication Date: 2026.02.10 VERTEX PHARMACEUTICALS INC
  • US12544545B2 patent drawing
  • US12544545B2 patent drawing
  • US12544545B2 patent drawing

AI summary

The present disclosure relates to macroencapsulation devices and related methods of manufacture where the membranes of a device may be mounted to an associated frame in a relaxed, or slack, configuration prior to filling with a desired material.